San Diego—An international multicenter trial has concluded that just under an hour of sevoflurane anesthesia during infancy does not increase the risk for adverse neurodevelopmental outcome at 2 years of age, relative to awake regional anesthesia. The finding is in contrast to some previous cohort studies.
According to Andrew J. Davidson, MD, senior anesthesiologist and director of the Melbourne Children’s Trials Centre at The Royal Children’s Hospital, in Melbourne,